As I mentioned earlier today, our key people, researches and management team are all involved in other activities, companies and projects, therefore, any number of situations could cause a delay in reporting, including the nature of clinical trials. I doubt that there is any requirement for a "peer review" prior to announcing the results of a scientific clinical trial.........sounds like fake news but I am no expert. For sure, the market is not happy and is taking it out on the stock price. Hopefully, we will hear something soon and at least reduce the uncertainty.